The policy implications of gender mainstreaming for healthcare research in the EU

PharmacoEconomics

Volumn 22, Issue SUPPL. 2, 2004, Pages 87-93

  Klinge, Ineke ^a   Maguire, Peggy ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b European Institute of Women's Health   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; CONFERENCE PAPER; EUROPE; FEMALE; FEMININITY; GENDER; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH STATUS; HUMAN; MEDICAL ETHICS; MEDICAL RESEARCH; MEDICAL SOCIETY; PRIORITY JOURNAL; PUBLIC HEALTH; SOCIOECONOMICS;

ECONOMICS, PHARMACEUTICAL; EUROPE; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; MALE; PUBLIC POLICY; SEX FACTORS; WOMEN'S HEALTH; WOMEN'S HEALTH SERVICES;

EID: 8344226841     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200422002-00010     Document Type: Conference Paper

References (14)

1. World Health Organization. Mainstreaming gender in health: the need to move forward. Madrid: World Health Organization, 2001
2. Eurostat. Luxembourg: Office for Official Publications of the European Communities, 1998
3. EIWH. Promoting gender equity in EU public health. Dublin: European Institute of Women's Health, 2000
4. Eurostat. Luxembourg: Office for Official Publications of the European Communities, 1999
5. Macintyre S, Hunt K, Sweeting H. Gender differences in health: are things as simple as they seem? Soc Sci Med 1996; 42 (4): 617-24
6. EIWH. Women in Europe: towards healthy ageing. Dublin: European Institute of Women's Health, 1996
7. Vademecum. Gender mainstreaming in the 6th Framework Programme: reference guide for scienctific officers/project officers. DG RTD, Unit 5. Women & Science, March 2003
8. Klinge I, Bosch M. Gender in research. Gender impact assessment of the specific programmes of the Fifth Framework Programme. Quality of life and management of living resources. Brussels: European Commission, 2001. Report No.: EUR 20017
9. Waals FW, Mohrs J, and Foets M. Sex differences among recipients of benzodiazepines in Dutch general practice. BMJ 1993; 307: 363-66
10. Blom AGTh, Paes AHP, Bakker A, et al. Drug consumption differences between men and women. Part 1 drug utilization data: part II explanations. Pharm Weekbl 1991; 126: 900-4; 924-9
11. Vliet K. van, Brezinska V, Lagro-Janssen T. Sex differences in the management of coronary artery disease: Evidence for gender-bias? In: Kolk A , Bekker M, van Vliet K, editors. Advances in women and health research. Towards gender sensitive strategies, Tilburg: Tilburg University Press, 1999; 85-102
12. Hamilton. On the inclusion of females in clinical trials in acute myocardial infarction. In: Sargent C, Bretell M, editors. Gender and health: an international perspective. New York: Prentice Hall, 1996
13. QLAM. Gender sensitivity in the assessment of health research by research ethics committee (REC's). Qlam-2001-00616; 2003
14. European Commission. Life sciences and biotechnology: a strategy for Europe. Communication of the European Commission. Brusssels: European Commission, 2002